Trials / Completed
CompletedNCT00002027
Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Janssen, LP · Industry
- Sex
- All
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of side effects as reported by patients at their visits and by frequent monitoring of hematology, biochemistries, and urinalysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclazuril |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002027. Inclusion in this directory is not an endorsement.